Recombinant Escherichia coli Cysteine desulfurase (iscS)

Shipped with Ice Packs
In Stock

Description

Basic Properties and Recombinant Expression

Recombinant IscS is expressed as a homodimer with a theoretical molecular weight of ~65.1 kDa, tagged with N-terminal His-SUMO and C-terminal Myc tags for purification and detection . Key properties include:

ParameterValue/Description
UniProt IDQ0TEV5
Host StrainE. coli O6:K15:H31 (strain 536 / UPEC)
StorageLiquid: Tris/PBS buffer with 5–50% glycerol; Lyophilized: Trehalose buffer, pH 8.0
Shelf Life6–12 months at −20°C/−80°C

IscS catalyzes the conversion of L-cysteine to L-alanine and elemental sulfur or selenium, serving as a sulfur donor for Fe-S clusters, molybdenum cofactors, and thiolated tRNAs .

Catalytic Mechanism and Active Site Residues

IscS operates via a PLP-dependent mechanism involving persulfide intermediates. Key steps include:

  1. Persulfide Formation: Cys328 attacks L-cysteine, releasing sulfur and forming a persulfide (Cys328-S-SH) .

  2. Redox Regulation: Activity is enhanced under reducing conditions (e.g., with dithiothreitol), increasing H₂S production ~2.6-fold .

  3. Intermediate Absorption Peaks:

    • Cys-ketimine: 338 nm (H104Q mutant) .

    • Cys-aldimine: 428 nm (K206A mutant) .

    • Alanine-quinonoid: 510 nm (oxidized red IscS) .

Critical residues include Lys206 (PLP binding) and Cys328 (substrate attack) . Mutations (e.g., K206A) trap intermediates, altering absorption spectra and catalytic efficiency .

Hydrogen Sulfide (H₂S) Production

IscS is the primary source of endogenous H₂S under anaerobic conditions, unlike 3-mercaptopyruvate sulfurtransferase (3-MST) in aerobic environments .

ConditionH₂S Activity (nmol·min⁻¹·mg⁻¹)Substrate
Anaerobic28 ± 2L-Cysteine + DTT
Anaerobic (No DTT)10.8 ± 1.5L-Cysteine

ΔiscS mutants show growth defects and low ATP under anaerobic conditions, reversible with exogenous Na₂S (500 μM) .

Red IscS Accumulation

Depletion of intracellular iron (via dipyridyl or ΔiscAΔsufA mutations) induces red IscS, characterized by a 528 nm absorption peak. This intermediate forms when IscS binds excess L-alanine and sulfide in vitro, mimicking iron-limited conditions .

ConditionAbsorption PeakProposed Intermediate
Wild-Type IscS395 nmPLP-bound active form
Red IscS528 nmAlanine-quinonoid persulfide

Partner Protein Interactions

IscS binds multiple acceptor proteins via distinct sites:

PartnerFunctionBinding Affinity
IscUFe-S cluster assembly scaffoldHigh
TusAMolybdenum cofactor biosynthesisModerate
ThiIThiamine biosynthesis and tRNA thiolationLow

TusA and IscU compete for IscS binding, regulating sulfur allocation between Fe-S clusters and molybdenum cofactors .

Functional Specificity and Evolutionary Conservation

IscS’s role is distinct from SufS (a paralog in the SUF system), which cannot support molybdenum cofactor or tRNA thiolation pathways . Human NFS1, a cysteine desulfurase, lacks IscS’s broad sulfur transfer capacity, highlighting evolutionary divergence in sulfur metabolism .

Applications and Future Directions

Recombinant IscS is used to study:

  • Fe-S Cluster Biogenesis: Elucidating IscS-IscU interactions and iron chaperone roles (e.g., IscA/SufA) .

  • Antimicrobial Targets: Exploiting IscS’s essentiality in pathogenic E. coli strains .

  • Biotechnological Tools: Engineering IscS variants for enhanced H₂S production or cofactor biosynthesis.

Product Specs

Form
Lyophilized powder. Note: We will preferentially ship the format we have in stock. If you have special format requirements, please specify them when ordering.
Lead Time
Delivery times may vary based on purchasing method and location. Please consult your local distributors for specific delivery times. Note: Proteins are shipped with blue ice packs by default. Request dry ice shipment in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
sufS; BWG_1494; Cysteine desulfurase; EC 2.8.1.7; Selenocysteine beta-lyase; SCL; Selenocysteine lyase; EC 4.4.1.16; Selenocysteine reductase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-406
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Escherichia coli (strain K12 / MC4100 / BW2952)
Target Names
sufS
Target Protein Sequence
MIFSVDKVRA DFPVLSREVN GLPLAYLDSA ASAQKPSQVI DAEAEFYRHG YAAVHRGIHT LSAQATEKME NVRKRASLFI NARSAEELVF VRGTTEGINL VANSWGNSNV RAGDNIIISQ MEHHANIVPW QMLCARVGAE LRVIPLNPDG TLQLETLPTL FDEKTRLLAI THVSNVLGTE NPLAEMITLA HQHGAKVLVD GAQAVMHHPV DVQALDCDFY VFSGHKLYGP TGIGILYVKE ALLQEMPPWE GGGSMIATVS LSEGTTWTKA PWRFEAGTPN TGGIIGLGAA LEYVSALGLN NIAEYEQNLM HYALSQLESV PDLTLYGPQN RLGVIAFNLG KHHAYDVGSF LDNYGIAVRT GHHCAMPLMA YYNVPAMCRA SLAMYNTHEE VDRLVTGLQR IHRLLG
Uniprot No.

Target Background

Function
Cysteine desulfurases convert L-cysteine to L-alanine, a crucial step in sulfur metabolism for synthesizing sulfur-containing biomolecules. Part of the suf operon, activated and required under conditions like oxidative stress and iron limitation. Acts as a potent selenocysteine lyase in vitro, releasing selenium from L-selenocysteine. In vivo selenocysteine lyase activity is uncertain.
Database Links

KEGG: ebw:BWG_1494

Protein Families
Class-V pyridoxal-phosphate-dependent aminotransferase family, Csd subfamily
Subcellular Location
Cytoplasm.

Q&A

What is cysteine desulfurase (IscS) and what is its primary function in E. coli?

Cysteine desulfurase (IscS) in Escherichia coli functions as a housekeeping enzyme and serves as a central hub for sulfur transfer in multiple cellular pathways. IscS catalyzes the conversion of L-cysteine to L-alanine while generating a protein-bound persulfide intermediate. This enzyme subsequently transfers the mobilized sulfur to various acceptor proteins that are involved in critical cellular processes. IscS plays essential roles in the assembly of iron-sulfur (Fe-S) clusters, biosynthesis of the molybdenum cofactor (Moco), and synthesis of thio-modified tRNAs, all of which share the same protein complex for essential sulfur mobilization . The enzyme prevents toxic accumulation of free sulfide by creating a controlled route for cellular sulfur transfer from donor to acceptor proteins through hetero-disulfide bond intermediates.

Which protein partners interact with IscS and for what cellular functions?

IscS interacts with multiple protein partners that bind at different sites on the enzyme surface. The major binding partners include:

  • Fe-S cluster assembly: IscU, Fdx (ferredoxin), CyaY, and IscX

  • Molybdenum cofactor biosynthesis: TusA

  • tRNA modifications: TusA (for mnm⁵s²U₃₄ tRNA modifications), ThiI (for s⁴U₈ tRNA modifications)

  • Thiamine biosynthesis: ThiI

Previous studies have established that most IscS partner proteins bind exclusively one at a time, with the notable exception of Fe-S cluster assembly, which involves the formation of ternary complexes including IscS, IscU, and either CyaY, Fdx, or IscX . The interaction with these various protein partners enables IscS to direct sulfur to multiple metabolic pathways as needed.

How does the competition between binding partners for IscS affect cellular sulfur distribution?

The competition between binding partners for IscS creates a regulatory mechanism for directing sulfur to different metabolic pathways. Research has shown that IscU and TusA compete for binding to IscS, with IscU having a higher affinity than TusA . This competition affects the distribution of sulfur between iron-sulfur cluster assembly and tRNA modification pathways.

The mechanism of sulfur distribution control appears to involve three key factors:

  • The relative cellular concentrations of sulfur acceptor proteins

  • The binding affinities of these proteins for IscS

  • The modulation of IscS desulfurase activity by different binding partners

When heterocomplexes form involving the IscS dimer with single IscU and TusA molecules, the L-cysteine desulfurase activity of IscS is affected, creating another layer of regulation. This competitive binding model suggests that cells can prioritize specific sulfur-requiring pathways by adjusting the levels of acceptor proteins or their binding affinities, providing a sophisticated control mechanism for sulfur metabolism .

What is the optimal protocol for recombinant expression of IscS in E. coli?

The optimal protocol for recombinant expression of IscS in E. coli typically involves the following methodological steps:

  • Vector and strain selection: Use expression vectors containing the IscS gene with appropriate tags (usually His-tag for easy purification) and antibiotic resistance markers. Transform these constructs into E. coli expression strains.

  • Culture conditions: Grow E. coli cells containing IscS expression constructs in LB medium supplemented with appropriate antibiotics (kanamycin at 50 μg/ml and chloramphenicol at 50 μg/ml have been used successfully) .

  • Induction parameters:

    • Monitor growth until the culture reaches an optical density (OD₆₀₀) of 0.6-0.8

    • Induce protein expression with 0.2 mM IPTG

    • Continue cultivation at 30°C for 16 hours after induction

  • Harvest and lysis:

    • Harvest cells by centrifugation

    • Resuspend in lysis buffer containing 50 mM phosphate buffered saline (pH 7.4), 300 mM NaCl, and 30 mM imidazole

    • Lyse cells using sonication with an Ultrasonic Cell Disruption System

    • Collect the supernatant by centrifugation at 12,000 rpm for 30 minutes at 4°C

This protocol has been demonstrated to produce sufficient quantities of functional IscS protein for biochemical and structural studies. The lower temperature (30°C) during the induction phase helps to ensure proper protein folding and reduce the formation of inclusion bodies.

How can the purity and activity of recombinant IscS be assessed?

Assessment of recombinant IscS purity and activity involves complementary analytical and functional approaches:

Purity Assessment:

  • SDS-PAGE analysis: The purified IscS protein typically appears as a single band at approximately 45 kDa on a 12% SDS-PAGE gel . Multiple bands or smearing may indicate degradation or contamination.

  • Gel filtration chromatography: To assess the oligomeric state and homogeneity of the purified protein.

  • Mass spectrometry: For precise molecular weight determination and to confirm the protein identity.

Activity Assessment:

  • H₂S production assay: Measure H₂S production using L-cysteine as a substrate. This can be quantified using:

    • Lead acetate precipitation method

    • Methylene blue formation

    • Fluorescent H₂S probes such as AzMC (λₑₓ = 365 nm)

  • Substrate specificity tests: Compare activity with different substrates such as L-cysteine versus S-methylcysteine. Studies have shown that DTT significantly enhances the H₂S-producing activity of IscS when using L-cysteine as a substrate .

  • Redox sensitivity analysis: Evaluate IscS activity under different redox conditions, as the enzyme's activity is redox-regulated. For instance, research has shown that 10 mM DTT provides optimal activity (approximately 59 nmol·min⁻¹·mg protein⁻¹) .

A properly purified and active IscS preparation should demonstrate consistent activity values across replicates and match published specific activity values when tested under standardized conditions.

What purification strategy yields the highest purity and retention of IscS activity?

The optimal purification strategy for obtaining high-purity, highly active recombinant IscS involves a multi-step chromatographic approach:

  • Immobilized metal affinity chromatography (IMAC):

    • Load the clarified cell lysate onto a HisTrap FF column pre-equilibrated with lysis buffer

    • Wash extensively to remove non-specifically bound proteins

    • Elute recombinant IscS with 300 mM imidazole in 50 mM PBS, pH 7.4

  • Buffer exchange/desalting:

    • Process the IMAC-purified protein through a HiTrap Desalting column equilibrated with 50 mM Tris-HCl, pH 8.0

    • This step is critical for removing imidazole, which can interfere with subsequent activity assays

  • Additional purification (if needed):

    • Ion exchange chromatography can be used to remove remaining impurities

    • Size exclusion chromatography can improve homogeneity and remove aggregates

  • Storage conditions:

    • Store purified IscS at -80°C in 50 mM Tris-HCl, pH 8.0, potentially with the addition of glycerol (10-20%) as a cryoprotectant

    • Aliquot the protein to avoid repeated freeze-thaw cycles, which can reduce activity

Critical parameters for activity retention:

  • Maintain reducing conditions throughout purification

  • Avoid prolonged exposure to room temperature

  • Include pyridoxal 5'-phosphate (PLP) in buffers, as IscS is a PLP-dependent enzyme

  • Determine protein concentration using the BCA protein assay with bovine serum albumin as a standard

This strategy consistently yields IscS preparations with >95% purity and high specific activity, suitable for structural and functional studies.

How does redox regulation affect IscS activity in vitro and in vivo?

IscS activity is significantly influenced by redox conditions both in vitro and in living E. coli cells, reflecting a sophisticated regulatory mechanism for controlling sulfur transfer in response to cellular redox status.

In vitro redox regulation:
Research demonstrates that IscS H₂S-producing activity is dramatically enhanced under reducing conditions. When using L-cysteine as a substrate, the addition of DTT (a reducing agent) significantly increases IscS activity compared to control conditions without DTT . Specifically:

  • With 10 mM DTT (optimal concentration), IscS exhibits its highest activity (~59 nmol·min⁻¹·mg protein⁻¹)

  • Activity decreases proportionally when DTT concentration is reduced

  • Under oxidizing conditions, IscS shows minimal activity

This redox sensitivity appears to be substrate-specific, as similar effects are observed when using S-methylcysteine as a substrate .

In vivo redox regulation:
The redox regulation observed in vitro also operates in living E. coli cells. Under anaerobic conditions, which create a more reducing cellular environment, IscS activity is enhanced. This has been demonstrated using fluorescent H₂S probes like AzMC to measure H₂S production in E. coli cell lysates .

The physiological significance of this redox regulation may relate to:

  • Protection of Fe-S clusters from oxidative damage

  • Coordination of IscS activity with cellular redox status

  • Adaptation of sulfur metabolism to environmental conditions

This redox sensitivity likely represents an important control mechanism that allows the cell to adjust IscS activity—and by extension, the rate of Fe-S cluster assembly and other sulfur-requiring processes—in response to changing redox conditions.

What structural features of IscS enable the formation of heterocomplexes with multiple partner proteins?

The structural versatility of IscS that enables its interaction with multiple partner proteins stems from several key architectural features:

  • Dimeric structure: IscS functions as a homodimer, with each monomer having distinct binding surfaces that can accommodate different partner proteins simultaneously. This allows for the formation of heterocomplexes involving the IscS dimer bound to different combinations of partner proteins .

  • Multiple binding interfaces: Crystal structure analysis has revealed that IscS contains several distinct binding surfaces that interact with different partner proteins:

    • IscU binds near the active site where the catalytic cysteine residue is located

    • TusA binds to a separate site that partially overlaps with the IscU binding region

    • CyaY, Fdx, and IscX interact with yet another surface of IscS

  • Flexible loop regions: The presence of flexible loops allows IscS to undergo conformational changes upon binding different partner proteins, optimizing the interaction interfaces.

These structural characteristics explain how IscS can form various complexes, including:

  • Binary complexes (IscS with either IscU or TusA)

  • Ternary complexes (IscS with IscU and either CyaY, Fdx, or IscX)

  • Heterocomplexes involving the IscS dimer with individual IscU and TusA molecules

The crystal structures of these complexes have revealed that while IscU and TusA compete for binding to the same region of IscS, they can also form heterocomplexes with the IscS dimer due to its dual binding capability. This structural arrangement allows IscS to function as a central hub for sulfur distribution, facilitating the controlled delivery of sulfur to different cellular pathways depending on which partner proteins are bound.

What are the binding affinities between IscS and its various partner proteins, and how do they influence sulfur transfer pathways?

The binding affinities between IscS and its partner proteins create a hierarchical system that determines sulfur distribution to various cellular pathways. These differential affinities form the basis for a competitive binding model that regulates sulfur metabolism.

Comparative binding affinities:
Research has established that different sulfur acceptor proteins have varying affinities for IscS, creating a preference hierarchy:

  • IscU binds to IscS with higher affinity than TusA, though both proteins have similar binding characteristics

  • The relative affinity ranking appears to be: IscU > TusA > other partner proteins

These differential affinities create a competition for binding to IscS, with consequences for sulfur distribution.

Influence on sulfur transfer pathways:
The varying binding affinities influence sulfur distribution in several ways:

  • Pathway prioritization: Higher-affinity binding partners like IscU receive preferential access to IscS, potentially prioritizing Fe-S cluster assembly over other pathways under standard conditions.

  • Responsive regulation: Changes in cellular concentrations of various acceptor proteins can overcome affinity differences, allowing lower-affinity partners to compete effectively when their levels are elevated.

  • Activity modulation: Binding of different partner proteins affects IscS desulfurase activity differently. For example, when both TusA and IscU bind to the IscS dimer, they modulate its L-cysteine desulfurase activity in a unique way compared to when only one partner is bound .

This system creates a flexible regulatory mechanism where:

  • Baseline priority is established by binding affinities

  • Dynamic control is achieved through changes in acceptor protein levels

  • Fine-tuning occurs via activity modulation when heterocomplexes form

This model explains how E. coli can coordinate the distribution of sulfur to multiple essential pathways using a single sulfur mobilization system centered on IscS, responding to changing cellular needs by adjusting the balance between competing pathways .

What are the most effective experimental designs to study IscS interaction networks?

Studying the complex interaction networks of IscS requires a multi-faceted experimental approach that combines biophysical, biochemical, and genetic techniques. The most effective experimental designs include:

  • Protein-protein interaction studies:

    • Surface plasmon resonance (SPR): For determining binding kinetics and affinities between IscS and its partner proteins. This allows quantitative measurement of association/dissociation rates and equilibrium constants.

    • Isothermal titration calorimetry (ITC): Provides thermodynamic parameters (ΔH, ΔS, ΔG) of binding interactions and exact stoichiometry.

    • Co-immunoprecipitation (Co-IP) with tagged versions of IscS to identify protein complexes formed in vivo.

  • Structural approaches:

    • X-ray crystallography of IscS in complex with different partner proteins individually and in combinations to visualize binding interfaces.

    • Cryo-electron microscopy (Cryo-EM) for analyzing larger complexes and dynamic interactions.

    • Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to map binding interfaces and conformational changes.

  • Functional assays:

    • Enzymatic activity assays measuring IscS desulfurase activity in the presence of different partner proteins.

    • Sulfur transfer tracking using radioactive labeling (³⁵S) or fluorescent probes to monitor sulfur movement from IscS to acceptor proteins.

    • Competition assays with varying concentrations of different partner proteins to study their relative binding preferences.

  • Genetic approaches:

    • Systematic mutagenesis of IscS binding interfaces to selectively disrupt specific protein-protein interactions.

    • Inducible expression systems to vary the relative concentrations of different partner proteins and observe effects on sulfur distribution pathways.

    • In vivo reporter systems to monitor pathway-specific outcomes (Fe-S cluster assembly, tRNA modification) when manipulating IscS interactions.

By combining these approaches, researchers can build a comprehensive understanding of how IscS orchestrates sulfur distribution through its complex network of interactions. This integrated approach allows for both mechanistic insights at the molecular level and functional validation in cellular contexts.

How can researchers troubleshoot issues with recombinant IscS stability and activity?

Troubleshooting stability and activity issues with recombinant IscS requires systematic evaluation of multiple parameters throughout the expression and purification process. The following methodological approach addresses common problems:

Expression-related issues:

ProblemPossible CausesSolutions
Low expression levelsCodon bias, toxicity, poor induction- Use codon-optimized gene
- Switch to T7 Express or BL21(DE3) strains
- Optimize induction parameters (lower IPTG to 0.2 mM, induce at OD₆₀₀ 0.6-0.8)
- Reduce growth temperature to 30°C post-induction
Inclusion body formationOver-expression, improper folding- Lower induction temperature (16-25°C)
- Reduce IPTG concentration
- Co-express with chaperones
- Use solubility-enhancing fusion tags

Purification-related issues:

ProblemPossible CausesSolutions
Protein degradationProteolysis during purification- Add protease inhibitors to lysis buffer
- Maintain samples at 4°C
- Reduce purification time
- Add EDTA to buffers (if compatible with purification method)
Poor His-tag bindingTag inaccessibility, improper buffer- Ensure proper pH of lysis buffer (7.4-8.0)
- Check imidazole concentration (30 mM in binding buffer)
- Verify tag is not cleaved/degraded
- Consider moving the tag to opposite terminus

Activity-related issues:

ProblemPossible CausesSolutions
Low/no enzymatic activityPLP cofactor loss, oxidative damage- Add PLP (0.1 mM) to buffers
- Ensure reducing environment (add 1-10 mM DTT)
- Check pH optimum (typically pH 8.0)
- Verify L-cysteine substrate quality
Activity inconsistencyBuffer incompatibility, protein instability- Standardize assay conditions
- Avoid repeated freeze-thaw cycles
- Use fresh DTT in activity assays
- Consider adding glycerol (10%) to storage buffer

Specific optimization strategies:

  • Cofactor reconstitution: If activity is low, incubate purified IscS with excess PLP (10-fold molar excess) and then remove unbound PLP by desalting.

  • Redox condition optimization: Systematically test activity across a range of DTT concentrations (1-20 mM) to determine the optimal reducing environment, as IscS activity is highly redox-sensitive .

  • Storage optimization: Test stability at different temperatures (-80°C, -20°C, 4°C) and in different buffer compositions to determine optimal storage conditions that preserve activity.

By systematically addressing these parameters, researchers can significantly improve the stability and activity of recombinant IscS preparations for subsequent structural and functional studies.

What are the current knowledge gaps and emerging research directions in IscS biology?

Despite significant advances in understanding IscS function, several critical knowledge gaps remain and are driving emerging research directions:

Current knowledge gaps:

  • Temporal regulation of interactions: While binding affinities between IscS and its partners are established, how these interactions are temporally coordinated in response to cellular needs remains poorly understood.

  • Post-translational modifications: The potential role of post-translational modifications in regulating IscS activity or partner binding selectivity has not been thoroughly investigated.

  • Structural dynamics in vivo: Most structural studies have been conducted with purified proteins in vitro. The actual conformational dynamics of IscS complexes in the cellular environment remain unclear.

  • Cross-talk with other cellular pathways: The integration of IscS-mediated sulfur transfer with other metabolic and stress response pathways needs further elucidation.

  • Species-specific differences: While E. coli IscS is well-studied, differences in functionality and regulation across bacterial species and between prokaryotic and eukaryotic homologs remain incompletely characterized.

Emerging research directions:

  • Systems biology approaches: Integrating multi-omics data (proteomics, metabolomics, transcriptomics) to understand how IscS functions within the broader cellular network and responds to environmental changes.

  • Single-molecule studies: Applying techniques like FRET and single-molecule tracking to observe the dynamics of IscS interactions and sulfur transfer events in real-time.

  • Synthetic biology applications: Engineering IscS and its interaction networks to create modified sulfur distribution systems for biotechnological applications.

  • Structural biology at higher resolution: Employing advanced cryo-EM and integrative structural biology approaches to visualize larger, more complex assemblies involving IscS.

  • Computational modeling: Developing predictive models of how changes in protein levels, binding affinities, and cellular conditions affect sulfur distribution through the IscS hub.

  • Pathogen-specific targeting: Exploring differences between host and pathogen IscS systems as potential targets for novel antimicrobials.

These research directions will likely lead to a more comprehensive understanding of how IscS functions as a central hub in cellular sulfur metabolism and how this system can be manipulated for both fundamental research and applied biotechnological purposes.

What are the key considerations when designing experiments involving recombinant IscS?

When designing experiments with recombinant IscS, researchers should consider multiple factors to ensure reliable and reproducible results:

  • Expression system optimization: Select an appropriate E. coli expression strain and vector system with consideration for codon usage and expression level control. Optimal expression typically involves induction with 0.2 mM IPTG at OD₆₀₀ 0.6-0.8, followed by cultivation at 30°C for 16 hours .

  • Purification strategy selection: Employ a multi-step purification process including IMAC followed by desalting/buffer exchange to ensure high purity and activity retention. Consider that buffer composition significantly impacts enzyme stability and activity .

  • Redox environment control: Maintain consistent reducing conditions throughout purification and experimental procedures, as IscS activity is highly redox-sensitive. The presence of 10 mM DTT has been shown to provide optimal activity conditions .

  • Partner protein considerations: When studying IscS interactions with partner proteins, account for their relative binding affinities and potential competition effects. The hierarchical binding preference (IscU > TusA > others) may necessitate careful adjustment of protein ratios .

  • Activity assay standardization: Establish standardized conditions for activity measurements, including consistent substrate concentrations, buffer composition, temperature, and detection methods. The H₂S-producing activity should be measured using reliable quantification methods under controlled redox conditions .

  • Storage and stability planning: Develop a storage protocol that maintains enzyme activity, typically involving aliquoting and storage at -80°C to prevent repeated freeze-thaw cycles. Include appropriate stabilizing agents if long-term storage is needed.

By systematically addressing these considerations in experimental design, researchers can maximize the reliability and reproducibility of their IscS studies, facilitating meaningful comparisons across different experimental conditions and between research groups.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.